share_log

Truist Securities Reiterates Buy on Compugen, Maintains $4 Price Target

Benzinga ·  Aug 23, 2023 22:15

Truist Securities analyst Asthika Goonewardene reiterates Compugen (NASDAQ:CGEN) with a Buy and maintains $4 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment